Research Topic · Peer-Reviewed

Breast and Ovarian Cancer

Breast and ovarian cancer are malignancies arising in the breast tissue and ovaries, respectively, representing significant causes of cancer-related morbidity and mortality in women worldwide. Research published in Women's Reproductive Health addresses multiple dimensions of these cancers, from genetic susceptibilit…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 26× across the literature 🔖 ISSN 2381-862X 🗓 Reviewed July 2026

Overview

Breast and ovarian cancer are malignancies arising in the breast tissue and ovaries, respectively, representing significant causes of cancer-related morbidity and mortality in women worldwide. Research published in Women's Reproductive Health addresses multiple dimensions of these cancers, from genetic susceptibility to novel therapeutic approaches. The journal has examined variants of uncertain clinical significance in BRCA1, a gene critically associated with hereditary breast and ovarian cancer risk, through functional and structural analysis to clarify their pathogenic potential. Investigations into treatment innovations include the development of pH-sensitive nanomedicine platforms specifically designed for gynecological cancers, exploiting the acidic tumor microenvironment to improve drug delivery and therapeutic efficacy. Additionally, research has explored molecular mechanisms that regulate cancer cell behavior, including studies on proteins that influence metastasis through modulation of cell adhesion molecules. The journal's coverage reflects the multifaceted nature of breast and ovarian cancer research, spanning genetic risk assessment, targeted drug delivery systems, and cellular mechanisms underlying cancer progression. Understanding these diverse aspects is essential for advancing early detection strategies, refining risk stratification, and developing more effective, personalized treatment options for women affected by these diseases.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

pH-Sensitive Nanomedicine for Treating Gynaecological Cancers

Vishwanath Prasad PramodCorresponding author
Center for Biomedical Research, Population Council, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
Women's Reproductive Health Cited by 8 doi:10.14302/issn.2381-862X.jwrh-19-3143

How this research is being cited

The 5 articles above have been cited 26 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Breast and Ovarian Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Women's Reproductive Health (ISSN 2381-862X).

Journal editorial board
Paolo Ivo Cavoretto · Italy Loc Nguyen · Hong Kong Matteo Schimberni · Italy

This page summarises published research for orientation; it is not medical or professional advice.